Andere talen Autolus Therapeutics plc

Aandelen

AUTL

US05280R1005

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,8 ^USD	-0,83%		-9,94%	-25,47%

18/04	Europese aandelen verhandeld in de VS als American Depositary Receipts vlak in de donderdaghandel	MT
11/04	Europese aandelen verhandeld in de VS als American Depositary Receipts dalen in de handel van donderdag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	18/04
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11/04
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	08/04
European Equities Close Lower Tuesday; Eurozone Manufacturing at 3-Month Low; Mining Stocks Rally, Real Estate Drops	02/04
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	02/04
Autolus Therapeutics Gets European Agency Approval for Marketing Authorization Application for Leukemia Treatment	02/04
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)	02/04
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)	02/04
Autolus Therapeutics Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)	02/04
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	02/04
Autolus Therapeutics Appoints Mike Bonney as Chair	01/04
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	01/04
Autolus Therapeutics Announces Changes to its Board of Directors	01/04
Autolus Therapeutics Announces Changes to its Board of Directors	01/04
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	25/03
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21/03
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	20/03
Autolus Therapeutics plc Announces Resignation of Edgar Braendle, Chief Development Officer	14/03
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Autolus Therapeutics plc

Aandelen

AUTL

US05280R1005

Andere talen

Filters